{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "E",
          "alt": "G",
          "position": 344
        },
        "variant_string_id": "PARK2 E344G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PARK2 is a ubiquitin E3 ligase that facilitates the ubiquitination of target proteins, leading to proteasome-mediated degradation. Mutations in PARK2 abrogate its ability to ubiquitinate cyclin E, resulting in mitotic instability and impaired tumor suppression.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the role of PARK2 in ubiquitination and its importance in tumor suppression."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used assays to measure ubiquitination function and colony-forming ability in cancer cells, which directly relate to PARK2's role in ubiquitination and tumor suppression.",
          "judgment": "Yes",
          "reasoning": "The assays used effectively model the disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: Experiments were performed in triplicate, and both wild-type and mutant PARK2 constructs were used as controls.\n\nStep 3c: Variant Controls: Known pathogenic variants were used as controls in the assays.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both wild-type and mutant controls were included, and experiments were replicated.\n\nStep 3c: Variant Controls: Known pathogenic variants were used as controls."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Not evaluated",
          "judgment": "Not evaluated",
          "reasoning": "No information provided in the paper"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The E344G mutation in PARK2 significantly compromises its ubiquitination activity and decreases colony-forming ability, strongly supporting its pathogenicity."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "Q",
          "position": 275
        },
        "variant_string_id": "PARK2 R275Q"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PARK2 is a ubiquitin E3 ligase that facilitates the ubiquitination of target proteins, leading to proteasome-mediated degradation. Mutations in PARK2 abrogate its ability to ubiquitinate cyclin E, resulting in mitotic instability and impaired tumor suppression.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the role of PARK2 in ubiquitination and its importance in tumor suppression."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used assays to measure ubiquitination function and colony-forming ability in cancer cells, which directly relate to PARK2's role in ubiquitination and tumor suppression.",
          "judgment": "Yes",
          "reasoning": "The assays used effectively model the disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: Experiments were performed in triplicate, and both wild-type and mutant PARK2 constructs were used as controls.\n\nStep 3c: Variant Controls: Known pathogenic variants were used as controls in the assays.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both wild-type and mutant controls were included, and experiments were replicated.\n\nStep 3c: Variant Controls: Known pathogenic variants were used as controls."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Not evaluated",
          "judgment": "Not evaluated",
          "reasoning": "No information provided in the paper"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The R275Q mutation in PARK2 significantly compromises its ubiquitination activity and decreases colony-forming ability, strongly supporting its pathogenicity."
    }
  ]
}